Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

Moderna CEO Stéphane Bancel received an annual compensation package worth $19.87 million last year, the largest he’s ever ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

Moderna stock is under pressure, again, as Robert F. Kennedy Jr. reportedly mulls pulling the company's federal funding to ...

Moderna is advancing its oncology portfolio with individualized neoantigen therapy (INT) and T-cell engagers. The company anticipates data readouts for melanoma and CMV vaccine trials in 2026 and ...

Introduction Vaccines are biological preparations that stimulate the immune system to develop protection against specific infectious diseases.

In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.

Now the nation’s top health official, Kennedy is reevaluating the US Health and Human Services’s contract with Moderna, which ...

With all the different messages and information about the COVID-19 vaccine, you may be wondering whether your little one ...